Physician Assistant · Dallas, TX
NPI
1295735900
Since 2005
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5201 Harry Hines Blvd, Medical Staff Services
Dallas, TX, 75235
Phone (214) 590-8006
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,951
125 services
Medicare patients, 2024
71
Average age 66
Drug cost, 2024
$1.4M
860 prescriptions
Company payments, 2025
$273
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marie Y Maitre was code 99214 (office e&m - established), 78 times for 60 patients. In total Marie Y Maitre billed 125 services in 13 codes, and Medicare paid $4,951.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 78 | 60 | $51.41 | $4,010 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 23 | $11.22 | $258 |
By year: 2022 $11K for 190 services; 2023 $8,449 for 163 services; 2024 $4,951 for 125 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marie Y Maitre prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 100 prescriptions and refills. In total Marie Y Maitre wrote 860 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 100 | 205 | 29 | $1,713 |
| Hydroxychloroquine Sulfate Generic | 76 | 160 | 39 | $3,963 |
| Enbrel Etanercept | 75 | 75 | Under 11 | $563K |
| Humira Adalimumab | 70 | 73 | 14 | $500K |
| Leflunomide Generic | 62 | 133 | 23 | $3,938 |
| Gabapentin Generic | 37 | 49 | 12 | $354 |
| Pantoprazole Sodium Generic | 37 | 57 | 15 | $234 |
| Cyclobenzaprine Hcl Generic | 33 | 39 | 16 | $239 |
| Azathioprine Generic | 28 | 52 | Under 11 | $2,551 |
| Sulfasalazine Generic | 22 | 45 | 11 | $643 |
| Prednisone Generic | 21 | 38 | 11 | $133 |
| Diclofenac Sodium Generic | 19 | 19 | Under 11 | $875 |
| Sulfasalazine Dr Sulfasalazine | 18 | 22 | Under 11 | $570 |
| Mycophenolate Mofetil Generic | 16 | 31 | Under 11 | $2,319 |
| Meloxicam Generic | 16 | 29 | Under 11 | $12.37 |
Brand drugs: 235 claims; generic drugs: 625 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marie Y Maitre $273 ($273 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $273 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.